Product Information
FEBUXOSTAT 80 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $0.3297 per EA under NDC 00527224832. Its NADAC has been published 192 times since Oct 26, 2022.
Strength
80 mg/1
Manufacturer
Lannett Company Inc.NDC
00527224832
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FEBUXOSTATApproval Type
Generic (ANDA)
FDA Application
ANDA213069On Market Since
6/2/2020
Pharmacological Classes
Price Statistics
The NADAC for FEBUXOSTAT 80 MG TABLET has been published 192 times since Oct 26, 2022, and over the history we have for it it has declined 61.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3297 per EA |
|---|---|
| All-time high | $0.8512 (Nov 16, 2022) |
| All-time low | $0.2636 (Feb 18, 2026) |
| 52-week high | $0.4893 |
| 52-week low | $0.2636 |
| Median price | $0.4894 |
| Average price | $0.5105 |
| Largest weekly change | +46.7% (Feb 22, 2023) |
| Weeks tracked | 192 |
| Tracking since | Oct 26, 2022 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FEBUXOSTAT 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 80 MG TABLET, manufactured by Lannett Company Inc., is $0.3297 per EA (NDC 00527224832), effective Jun 24, 2026.
How has the price of FEBUXOSTAT 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEBUXOSTAT 80 MG TABLET has declined 61.3%. It has been tracked across 192 weekly CMS publications since Oct 26, 2022.
What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 80 MG TABLET?
Since Oct 26, 2022, the NADAC for FEBUXOSTAT 80 MG TABLET has ranged from a low of $0.2636 (Feb 18, 2026) to a high of $0.8512 (Nov 16, 2022), with a median of $0.4894 per EA.
Are there cheaper alternatives to FEBUXOSTAT 80 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as FEBUXOSTAT 80 MG TABLET, but none are currently priced below it.
Who manufactures FEBUXOSTAT 80 MG TABLET?
FEBUXOSTAT 80 MG TABLET (NDC 00527224832) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification